{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:10:35Z","timestamp":1790712635094,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":4842,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1017\/s104161021100024x","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T11:18:41Z","timestamp":1300792721000},"page":"1240-1248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Assessment of antipsychotic prescribing in Belgian nursing homes"],"prefix":"10.1016","volume":"23","author":[{"given":"Majda","family":"Azermai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Elseviers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"van Bortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert der","family":"Van Stichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S104161021100024X_bb0010","unstructured":"Azermai M. , ElseviersM., PetrovicM. and Vander SticheleR. (in press). Geriatric drug utilisation of psychotropics in Belgian nursing homes. Human Psychopharmacology: Clinical and Experimental."},{"key":"10.1017\/S104161021100024X_bb0015","doi-asserted-by":"crossref","unstructured":"Ballard C. and WaiteJ. (2006). The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews, CD003476.","DOI":"10.1002\/14651858.CD003476.pub2"},{"key":"10.1017\/S104161021100024X_bb0020","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0050076","article-title":"A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)","volume":"5","author":"Ballard","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1017\/S104161021100024X_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1017\/S104161021100024X_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2318-9-30","article-title":"Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort","volume":"9","author":"Berdot","year":"2009","journal-title":"BMC Geriatrics"},{"key":"10.1017\/S104161021100024X_bb0035","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.165.11.1280","article-title":"The quality of antipsychotic drug prescribing in nursing homes","volume":"165","author":"Briesacher","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1017\/S104161021100024X_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjopharm.2009.05.001","article-title":"Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006","volume":"7","author":"Castle","year":"2009","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S104161021100024X_bb0045","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/pds.1983","article-title":"Drug utilization in Belgian nursing homes: impact of residents\u2019 and institutional characteristics","volume":"19","author":"Elseviers","year":"2010","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1017\/S104161021100024X_bb0050","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Archives of Interal Medicine"},{"key":"10.1017\/S104161021100024X_bb0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation","volume":"46","author":"Gallagher","year":"2008","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1017\/S104161021100024X_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3956(01)00020-6","article-title":"Treatment with atypical antipsychotics: new indications and new populations","volume":"35","author":"Glick","year":"2001","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S104161021100024X_bb0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A method for assessing drug therapy appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1017\/S104161021100024X_bb0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00002512-200522040-00006","article-title":"Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes. How successful have they been?","volume":"22","author":"Hughes","year":"2005","journal-title":"Drugs and Aging"},{"key":"10.1017\/S104161021100024X_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.amjopharm.2008.10.002","article-title":"Antipsychotic drug use among elderly nursing home residents in the United States","volume":"6","author":"Kamble","year":"2008","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S104161021100024X_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2190\/UURL-2RYU-WRYD-EY3K","article-title":"A measure of primary sociobiological functions","volume":"6","author":"Katz","year":"1976","journal-title":"International Journal of Health Services"},{"key":"10.1017\/S104161021100024X_bb0085","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/gerona\/60.5.622","article-title":"Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study","volume":"60","author":"Landi","year":"2005","journal-title":"Journals of Gerontology, Series A: Biological Sciences and Medical Science"},{"key":"10.1017\/S104161021100024X_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157015908784533860","article-title":"Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)","volume":"6","author":"Liperoti","year":"2008","journal-title":"Current Neuropharmacology"},{"key":"10.1017\/S104161021100024X_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2318-9-18","article-title":"Psychotropic medication use among nursing home residents in Austria: a cross-sectional study","volume":"9","author":"Mann","year":"2009","journal-title":"BMC Geriatrics"},{"key":"10.1017\/S104161021100024X_bb0100","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"American Family Physician"},{"key":"10.1017\/S104161021100024X_bb0105","first-page":"103","article-title":"Development and validation of an improving prescribing in the elderly tool","volume":"7","author":"Naugler","year":"2000","journal-title":"Canadian Journal of Clinical Pharmacology"},{"key":"10.1017\/S104161021100024X_bb0110","unstructured":"National Institute for Health and Clinical Excellence (2006). The NICE-SCIE guideline on Supporting People with Dementia and their Carers. Available at http:\/\/www.nice.org.uk\/nicemedia\/live\/10998\/30318\/30318.pdf; last accessed September 2010."},{"key":"10.1017\/S104161021100024X_bb0115","first-page":"173","article-title":"Evaluation of prescribing quality in nursing homes based on drug-specific indicators: the Bergen district nursing home (BEDNURS) study","volume":"18","author":"Ruths","year":"2008","journal-title":"Norsk Epidemiologi"},{"key":"10.1017\/S104161021100024X_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/qhc.12.3.176","article-title":"Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study","volume":"12","author":"Ruths","year":"2003","journal-title":"Quality and Safety in Health Care"},{"key":"10.1017\/S104161021100024X_bb0125","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1017\/S104161021100024X_bb0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00003","article-title":"Assessing care of vulnerable elders: methods for developing quality indicators","volume":"135","author":"Shekelle","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1017\/S104161021100024X_bb0135","unstructured":"Scottish Intercollegiate Guidelines Network (2006). Guideline for the Management of Patients with Dementia. Available at: http:\/\/www.sign.ac.uk\/pdf\/sign86.pdf; last accessed September 2010."},{"key":"10.1017\/S104161021100024X_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/gps.2414","article-title":"Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England","volume":"25","author":"Testad","year":"2010","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S104161021100024X_bb0145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pds.1334","article-title":"All-cause mortality associated with atypical and typical antipsychotics in demented outpatients","volume":"16","author":"Trifiro","year":"2007","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1017\/S104161021100024X_bb0150","unstructured":"US Food and Drug Administration (2005). Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/UCM053171; last accessed June 2010."},{"key":"10.1017\/S104161021100024X_bb0155","unstructured":"US Food and Drug Administration (2008). Information for Healthcare Professionals: Conventional Antipsychotics. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124830.htm; last accessed June 2010."}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224021902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224021902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S104161021100024X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T14:10:53Z","timestamp":1735827053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224021902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1041610224021902"],"URL":"https:\/\/doi.org\/10.1017\/s104161021100024x","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of antipsychotic prescribing in Belgian nursing homes","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S104161021100024X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Copyright \u00a9 International Psychogeriatric Association 2011. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}